These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Dopamine receptor binding of a novel dibenzodioxazocine derivative, EGYT-2509. Gyüre K, Szentendrei T, Kanyicska B, Fekete MI, Rónai AZ. Pol J Pharmacol Pharm; 1985; 37(3):253-61. PubMed ID: 2866498 [Abstract] [Full Text] [Related]
24. Pharmacokinetics of phenothiazine neuroleptics after chronic coadministration of carbamazepine. Daniel WA, Syrek M, Haduch A, Wójcikowski J. Pol J Pharmacol; 1998; 50(6):431-42. PubMed ID: 10385926 [Abstract] [Full Text] [Related]
25. The agonist activities of the putative antipsychotic agents, L-745,870 and U-101958 in HEK293 cells expressing the human dopamine D4.4 receptor. Gazi L, Bobirnac I, Danzeisen M, Schüpbach E, Bruinvels AT, Geisse S, Sommer B, Hoyer D, Tricklebank M, Schoeffter P. Br J Pharmacol; 1998 Jul; 124(5):889-96. PubMed ID: 9692773 [Abstract] [Full Text] [Related]
30. Radio receptor assay of serum neuroleptic levels in psychiatric patients. Krska J, Sampath G, Shah A, Soni SD. Br J Psychiatry; 1986 Feb; 148():187-93. PubMed ID: 2870755 [Abstract] [Full Text] [Related]
31. Affinity of cyamemazine metabolites for serotonin, histamine and dopamine receptor subtypes. Benyamina A, Arbus C, Nuss P, Garay RP, Neliat G, Hameg A. Eur J Pharmacol; 2008 Jan 14; 578(2-3):142-7. PubMed ID: 17936750 [Abstract] [Full Text] [Related]
32. Modification of the radioreceptor assay technique for estimation of serum neuroleptic drug levels leads to improved precision and sensitivity. Rao ML. Psychopharmacology (Berl); 1986 Jan 14; 90(4):548-53. PubMed ID: 2880364 [Abstract] [Full Text] [Related]
33. Binding of perazine to alpha 1-acid glycoprotein. Schley J, Siegert M, Müller-Oerlinghausen B. Eur J Clin Pharmacol; 1980 Nov 14; 18(6):501-4. PubMed ID: 6109633 [Abstract] [Full Text] [Related]
34. Gas-liquid chromotographic determination of perazine, thioridazine and thioridazine metabolites in human plasma. Vanderheeren FA, Theunis DJ. J Chromatogr; 1976 May 12; 120(1):123-8. PubMed ID: 5459 [Abstract] [Full Text] [Related]
35. Neuroleptic serum levels measured by radioreceptor assay and clinical response in schizophrenic patients. Tune LE, Creese I, DePaulo JR, Slavney PR, Snyder SH. J Nerv Ment Dis; 1981 Jan 12; 169(1):60-3. PubMed ID: 6108981 [Abstract] [Full Text] [Related]
36. Pharmacological studies on perazine and its primary metabolites. Brand U, Menge HG, Neumann BW, Stille G. Pharmacopsychiatry; 1989 Nov 12; 22(6):255-7. PubMed ID: 2575764 [Abstract] [Full Text] [Related]
37. High affinity binding of perazine and desmethylperazine to human alpha 1-acid glycoprotein. Schley J, Nündel M, Siegert M, Riedel E, Müller-Oerlinghausen B. Pharmakopsychiatr Neuropsychopharmakol; 1980 May 12; 13(3):144-5. PubMed ID: 6104826 [No Abstract] [Full Text] [Related]
38. Early serum levels of neuroleptics do not predict therapeutic response in schizophrenia. Gaebel W, Müller-Oerlinghausen B, Schley J. Prog Neuropsychopharmacol Biol Psychiatry; 1992 May 12; 16(6):891-900. PubMed ID: 1355303 [Abstract] [Full Text] [Related]
39. [Comparative investigations of the binding of perazine dimalonate (PDM) to human and bovine serum albumin (author's transl)]. Kinawi A, Min K. Arch Pharm (Weinheim); 1979 Mar 12; 312(3):205-13. PubMed ID: 35132 [No Abstract] [Full Text] [Related]
40. Binding of tricyclic antidepressants and perazine to human plasma. Methodology and findings in normals. Brinkschulte M, Breyer-Pfaff U. Naunyn Schmiedebergs Arch Pharmacol; 1979 Jul 12; 308(1):1-7. PubMed ID: 40137 [No Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]